Marianne Alanko Blomé
1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Clinical and epidemiological characteristics of Legionnaires' disease in Southern Sweden, a population-based study
- Contribution to journal › Article
-
Mark
Evolving insights into viral hepatitis : Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) – Part 2: hepatitis B, C, and delta
- Contribution to journal › Scientific review
-
Mark
Evolving insights into viral hepatitis : Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) Part 1: hepatitis A, E, and herpesvirus-associated liver disease
- Contribution to journal › Article
- 2024
-
Mark
Distribution of intranasal naloxone to potential opioid overdose bystanders in Sweden : Effects on overdose mortality in a full region-wide study
- Contribution to journal › Article
-
Mark
Staphylococcus aureus carriage and prevalence of skin and soft tissue infections among people who inject drugs : a longitudinal study
- Contribution to journal › Article
- 2022
-
Mark
Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
- Contribution to journal › Article
- 2021
-
Mark
Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection
- Contribution to journal › Article
-
Mark
Hepatitis C elimination in Sweden : Progress, challenges and opportunities for growth in the time of COVID-19
- Contribution to journal › Article
-
Mark
Hepatitis C treatment at a Swedish needle exchange program, a successful model of care – the ACTIONNE study
- Contribution to journal › Article
- 2020
-
Mark
High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder
- Contribution to journal › Article
